BigClassActions.com
Advertisement

Arena Pharmaceuticals Inc ARNA Securities Stock Fraud

- by

Company: Arena Pharmaceuticals Inc
Ticker Symbol: ARNA
Class Period: Mar-30-09 to Sep-17-10
Date Filed: Sep-21-10
Lead Plaintiff Deadline: Nov-20-10
Court: Southern District of California
Allegations:
New York, NY: A securities fraud class action lawsuit has been filed on behalf of those investors who acquired the securities of Arena Pharmaceuticals, Inc. ("Arena" or the "Company") during the period March 30, 2009 to September 17, 2010, inclusive (the "Class Period"). The lawsuit is pending in the United States District Court for the Southern District of California and names as defendants Arena and certain of its top officers.

According to the complaint, the defendants made several statements during the Class Period about the Company's weight loss drug lorcaserin which were false and misleading because they omitted and failed to disclose that tests for lorcaserin indicated that the drug caused cancer in lab rats. When the results of the rat carcinogenicity studies became public on September 14, 2010, the Company's stock fell from a closing price of $6.85 on September 13, 2010, to a closing price of $4.13 on September 14, 2010, a one day drop of $2.72 or roughly 40%, according to the complaint. On September 16, 2010, the FDA's advisory committee held a meeting to review lorcaserin and, according to the complaint, rejected the drug in light of the concern that the potential risks of long-term use, including the risk of cancer, outweighed its benefit. As a result of this news, the Company's stock fell from a closing price of $3.74 on September 16, 2010 to a closing price of $1.99 on September 17, 2010, a one day drop of $1.75 or roughly 46%, according to the complaint.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Arena Pharmaceuticals Inc ARNA Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Arena Pharmaceuticals Inc securities class action lawsuit. Please fill in our form on the right to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Request Legal Help